{"count": 6, "results": [{"_id": "36739490", "pmid": 36739490, "title": "Contrast-induced Nephropathy in Kidney Transplant Recipients: A Single-center Experience.", "journal": "Iran J Kidney Dis", "authors": ["Gheith OA", "Nagib AM", "Halim MA", "Mahmoud T", "Nair P", "Abo-Atya H", "Shaker M", "Mostafa M", "Attia H", "Alotaibi T"], "date": "2023-01-01T00:00:00Z", "meta_date_publication": "2023 Jan", "meta_volume": "1", "meta_issue": "1", "meta_pages": "47-53", "score": 50249.887, "text_hl": "@<m>DISEASE_Extravasation_of_Diagnostic_and_Therapeutic_Materials</m> @DISEASE_MESH:D005119 @@@CIN@@@ was defined as an increase in serum @CHEMICAL_Creatinine @CHEMICAL_MESH:D003404 @@@creatinine@@@ of 25% from the baseline within 72 hours. ", "citations": {"NLM": "Gheith OA, Nagib AM, Halim MA, Mahmoud T, Nair P, Abo-Atya H, Shaker M, Mostafa M, Attia H, Alotaibi T. Contrast-induced Nephropathy in Kidney Transplant Recipients: A Single-center Experience. Iran J Kidney Dis. 2023 Jan;1(1):47-53. PMID: 36739490", "BibTeX": "@article{36739490, title={Contrast-induced Nephropathy in Kidney Transplant Recipients: A Single-center Experience.}, author={Gheith OA and Nagib AM and Halim MA and Mahmoud T and Nair P and Abo-Atya H and Shaker M and Mostafa M and Attia H and Alotaibi T}, journal={Iran J Kidney Dis}, volume={1}, number={1}, pages={47-53}}"}}, {"_id": "29111980", "pmid": 29111980, "pmcid": "PMC5731282", "title": "Impact of continuation of metformin prior to elective coronary angiography on acute contrast nephropathy in patients with normal or mildly impaired renal functions", "journal": "Anatol J Cardiol", "authors": ["Oktay V", "Calpar Çıralı İ", "Sinan ÜY", "Yıldız A", "Ersanlı MK"], "date": "2017-11-01T00:00:00Z", "doi": "10.14744/AnatolJCardiol.2017.7836", "meta_date_publication": "2017 Nov", "meta_volume": "18", "meta_issue": "5", "meta_pages": "334-339", "score": 50068.633, "text_hl": "@<m>DISEASE_Extravasation_of_Diagnostic_and_Therapeutic_Materials</m> @DISEASE_MESH:D005119 @@@CIN@@@ at 48 h was 8% (11/134) in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ continued group and 6% (8/134) in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ discontinued group (p=0.265). ", "citations": {"NLM": "Oktay V, Calpar Çıralı İ, Sinan ÜY, Yıldız A, Ersanlı MK. Impact of continuation of metformin prior to elective coronary angiography on acute contrast nephropathy in patients with normal or mildly impaired renal functions Anatol J Cardiol. 2017 Nov;18(5):334-339. PMID: 29111980", "BibTeX": "@article{29111980, title={Impact of continuation of metformin prior to elective coronary angiography on acute contrast nephropathy in patients with normal or mildly impaired renal functions}, author={Oktay V and Calpar Çıralı İ and Sinan ÜY and Yıldız A and Ersanlı MK}, journal={Anatol J Cardiol}, volume={18}, number={5}, pages={334-339}}"}}, {"_id": "24008523", "pmid": 24008523, "title": "[Nephrotoxicity due to iodine contrasts in computerized tomography studies of diabetic outpatients on metformin].", "journal": "An Sist Sanit Navar", "authors": ["Gómez Herrero H", "De Arriba Villamor C", "Buldain Parra M", "Arraiza Sarasa M"], "date": "2013-09-06T00:00:00Z", "doi": "10.4321/s1137-66272013000200003", "meta_date_publication": "2013 Sep 6", "meta_volume": "36", "meta_issue": "2", "meta_pages": "197-201", "score": 50067.105, "text_hl": "BACKGROUND: To determine the incidence of @<m>DISEASE_Extravasation_of_Diagnostic_and_Therapeutic_Materials</m> @DISEASE_MESH:D005119 @@@contrast@@@-induced @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@nephropathy@@@ (@<m>DISEASE_Extravasation_of_Diagnostic_and_Therapeutic_Materials</m> @DISEASE_MESH:D005119 @@@CIN@@@) among @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ who underwent computerized tomography (CT) scan with iodinated contrast media. ", "citations": {"NLM": "Gómez Herrero H, De Arriba Villamor C, Buldain Parra M, Arraiza Sarasa M. [Nephrotoxicity due to iodine contrasts in computerized tomography studies of diabetic outpatients on metformin]. An Sist Sanit Navar. 2013 Sep 6;36(2):197-201. PMID: 24008523", "BibTeX": "@article{24008523, title={[Nephrotoxicity due to iodine contrasts in computerized tomography studies of diabetic outpatients on metformin].}, author={Gómez Herrero H and De Arriba Villamor C and Buldain Parra M and Arraiza Sarasa M}, journal={An Sist Sanit Navar}, volume={36}, number={2}, pages={197-201}}"}}, {"_id": "30119251", "pmid": 30119251, "title": "Involvement of organic cation transporter 2 in the metformin-associated increased lactate levels caused by contrast-induced nephropathy.", "journal": "Biomed Pharmacother", "authors": ["Yang S", "Dai Y", "Liu Z", "Wang C", "Meng Q", "Huo X", "Sun H", "Ma X", "Peng J", "Liu K"], "date": "2018-10-01T00:00:00Z", "doi": "10.1016/j.biopha.2018.07.068", "meta_date_publication": "2018 Oct", "meta_volume": "106", "meta_issue": "", "meta_pages": "1760-1766", "score": 50066.453, "text_hl": "The uptake of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ decreased in kidney slices in the @<m>DISEASE_Extravasation_of_Diagnostic_and_Therapeutic_Materials</m> @DISEASE_MESH:D005119 @@@CIN@@@ group. ", "citations": {"NLM": "Yang S, Dai Y, Liu Z, Wang C, Meng Q, Huo X, Sun H, Ma X, Peng J, Liu K. Involvement of organic cation transporter 2 in the metformin-associated increased lactate levels caused by contrast-induced nephropathy. Biomed Pharmacother. 2018 Oct;106():1760-1766. PMID: 30119251", "BibTeX": "@article{30119251, title={Involvement of organic cation transporter 2 in the metformin-associated increased lactate levels caused by contrast-induced nephropathy.}, author={Yang S and Dai Y and Liu Z and Wang C and Meng Q and Huo X and Sun H and Ma X and Peng J and Liu K}, journal={Biomed Pharmacother}, volume={106}, pages={1760-1766}}"}}, {"_id": "28656510", "pmid": 28656510, "title": "Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy.", "journal": "Int Urol Nephrol", "authors": ["Wang J", "Ai X", "Li L", "Gao Y", "Sun N", "Li C", "Sun W"], "date": "2017-11-01T00:00:00Z", "doi": "10.1007/s11255-017-1639-2", "meta_date_publication": "2017 Nov", "meta_volume": "49", "meta_issue": "11", "meta_pages": "2019-2026", "score": 50062.156, "text_hl": "We evaluated the protective effects of @CHEMICAL_Alprostadil @CHEMICAL_MESH:D000527 @@@alprostadil@@@ on @<m>DISEASE_Extravasation_of_Diagnostic_and_Therapeutic_Materials</m> @DISEASE_MESH:D005119 @@@CIN@@@ in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@ @SPECIES_9606 @@@patients@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ after contrast media (CM) administration. ", "citations": {"NLM": "Wang J, Ai X, Li L, Gao Y, Sun N, Li C, Sun W. Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy. Int Urol Nephrol. 2017 Nov;49(11):2019-2026. PMID: 28656510", "BibTeX": "@article{28656510, title={Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy.}, author={Wang J and Ai X and Li L and Gao Y and Sun N and Li C and Sun W}, journal={Int Urol Nephrol}, volume={49}, number={11}, pages={2019-2026}}"}}, {"_id": "21641061", "pmid": 21641061, "title": "Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice.", "journal": "Int J Cardiol", "authors": ["Tziakas D", "Chalikias G", "Stakos D", "Apostolakis S", "Adina T", "Kikas P", "Alexoudis A", "Passadakis P", "Thodis E", "Vargemezis V", "Konstantinides S"], "date": "2013-02-10T00:00:00Z", "doi": "10.1016/j.ijcard.2011.05.079", "meta_date_publication": "2013 Feb 10", "meta_volume": "163", "meta_issue": "1", "meta_pages": "46-55", "score": 50049.85, "text_hl": "Multivariable logistic regression analysis was then performed to identify independent predictors of @<m>DISEASE_Extravasation_of_Diagnostic_and_Therapeutic_Materials</m> @DISEASE_MESH:D005119 @@@CIN@@@ (pre-existing @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@renal disease@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use, history of previous PCI, @DISEASE_Peripheral_Arterial_Disease @DISEASE_MESH:D058729 @@@peripheral arterial disease@@@ and >= 300 ml of contrast volume). ", "citations": {"NLM": "Tziakas D, Chalikias G, Stakos D, Apostolakis S, Adina T, Kikas P, Alexoudis A, Passadakis P, Thodis E, Vargemezis V, Konstantinides S. Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice. Int J Cardiol. 2013 Feb 10;163(1):46-55. PMID: 21641061", "BibTeX": "@article{21641061, title={Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice.}, author={Tziakas D and Chalikias G and Stakos D and Apostolakis S and Adina T and Kikas P and Alexoudis A and Passadakis P and Thodis E and Vargemezis V and Konstantinides S}, journal={Int J Cardiol}, volume={163}, number={1}, pages={46-55}}"}}]}